COMMUNIQUÉS West-GlobeNewswire

Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
09/02/2018
CAS Group Supports Improved Deal Company Currently has Sufficient Votes to Approve Merger ATLANTA, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) today announced that the reconvened [...]
INSYS Therapeutics Addresses Maryland Attorney General’s Motion
09/02/2018
PHOENIX, Feb. 09, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the [...]
American College of Rheumatology Praises Congressional Leaders for Passing Spending Bill that Includes Part B Fix, Therapy Caps Repeal
09/02/2018
Washington, DC, Feb. 09, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology praises Congressional leaders for passing today’s sweeping spending agreement, which includes a technical provision reversing a [...]
LifePoint Health To Broadcast Its Fourth Quarter And Year-End 2017 Conference Call Live On The Internet
09/02/2018
Brentwood, Tenn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LifePoint Health, Inc. (NASDAQ: LPNT) announced today that it will provide an online Web simulcast of its fourth quarter and year-end 2017 conference call on Friday, [...]
BioStem Technologies Inc. Announces New Transfer Agent, V Stock Transfer
09/02/2018
Pompano Beach, FL, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Pompano Beach, FL (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (the “Company”) announced today that it has changed the transfer agent and registrar [...]
Chiesi USA, Inc. Certified As a Top Employer in the US for Third Consecutive Year
09/02/2018
CARY, N.C., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee) announced today the company was recognized as a Top Employer in the United States for the third year running. The award is certified by the Top [...]
LB-100 and LB-102, Lixte Biotechnology’s Protein Phosphatase 2A Inhibitors, Sensitize BCR-ABL Leukemia Stem Cells to Targeted Therapy with Tyrosine Kinase Inhibitors
09/02/2018
EAST SETAUKET, NY, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) noted that investigators at the Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, [...]
Sienna Senior Living Inc. Announces Closing of Common Share Offering for Gross Proceeds of Approximately $160 Million
09/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) [...]
Canada House Wellness Group’s COO, Riley McGee Interviewed on the Midas Letter
09/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to [...]
Oncobiologics Announces Term Extension of Series A Warrants
09/02/2018
CRANBURY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) (NASDAQ: ONSIW ) (NASDAQ: ONSIZ ) announced today an extension to the term for exercise of its publicly traded Series A warrants ( [...]
Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter
09/02/2018
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announces preliminary, unaudited revenues for the 4 th quarter of 2017 of approximately $945,000, [...]
Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing
09/02/2018
LEXINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, is announcing the [...]
Dermira to Present at Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
MENLO PARK, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Dr. Alfredo Hoyos Opens First InMode International BodyTite Training Center
09/02/2018
LAKE FOREST, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- InMode Aesthetic Solutions, a leader in aesthetic medicine and technology, is proud to announce the opening of the first official International InMode BodyTite [...]
Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor
09/02/2018
--Enrollment target reached; topline data on track for Q3 2018 announcement-- NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical [...]
Globus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call
09/02/2018
AUDUBON, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December [...]
HMS Holdings Corp. To Report Fourth Quarter and Full Year 2017 Financial and Operating Results
09/02/2018
IRVING, Texas, Feb. 09, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (NASDAQ: HMSY ) today announced it will report fourth quarter and full year 2017 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, [...]
Auris Medical Announces Extraordinary General Meeting of Shareholders
09/02/2018
Proposed capital restructuring to ensure compliance with Nasdaq minimum bid price rule contingent on Company's share price development Alain Munoz proposed as new member of the Board of the Directors Zug, Switzerland, [...]
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference
09/02/2018
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference Two Phase 1 trials to start in 2018 for A 2A receptor antagonist and [...]

Pages